Table III.
Factor | Observation group (n=45) | Control group (n=41) | t/χ2 test | P-value |
---|---|---|---|---|
Sex (n, %) | 0.001 | 0.984 | ||
Male | 24 (53.33) | 21 (51.22) | ||
Female | 21 (46.67) | 20 (48.78) | ||
Age | 17.86±3.49 | 17.75±3.52 | 0.145 | 0.885 |
Respiratory rate | 37.86±3.49 | 38.25±3.52 | 0.515 | 0.608 |
Long-term bed rest (n, %) | 0.007 | 0.935 | ||
Yes | 19 (42.22) | 16 (39.02) | ||
No | 26 (57.78) | 25 (60.98) | ||
Repeated infection (n, %) | 9.291 | 0.002 | ||
Yes | 37 (82.22) | 20 (48.78) | ||
No | 8 (17.78) | 21 (51.22) | ||
SOFA score | 9.85±3.13 | 7.32±3.18 | 3.716 | <0.001 |
PCT (ng/ml) | 5.89±3.23 | 3.36±3.28 | 3.601 | 0.001 |
D-D (ng/ml) | 847.89±31.43 | 523.83±26.34 | 51.549 | <0.001 |
CRP (mg/l) | 127.35±14.23 | 67.37±9.26 | 22.922 | <0.001 |
Multi-resistant bacterial infection | 16.560 | <0.001 | ||
Yes | 35 (77.78) | 17 (41.46) | ||
No | 10 (22.22) | 24 (58.54) |
SCAP, severe community-acquired pneumonia; SOFA, sequential organ failure assessment; PCT, procalcitonin; D-D, D-dimer; CRP, C-reactive protein.